These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11885278)

  • 1. Reversible oxidation of HIV-2 protease.
    Davis DA; Newcomb FM; Moskovitz J; Fales HM; Levine RL; Yarchoan R
    Methods Enzymol; 2002; 348():249-59. PubMed ID: 11885278
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase.
    Davis DA; Newcomb FM; Moskovitz J; Wingfield PT; Stahl SJ; Kaufman J; Fales HM; Levine RL; Yarchoan R
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):305-11. PubMed ID: 10677347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsite preferences of retroviral proteinases.
    Dunn BM; Gustchina A; Wlodawer A; Kay J
    Methods Enzymol; 1994; 241():254-78. PubMed ID: 7854181
    [No Abstract]   [Full Text] [Related]  

  • 4. Time dependent heterodimer formation leads to inhibition of HIV protease activity.
    Babé LM; Craik CS
    Adv Exp Med Biol; 1991; 306():543-7. PubMed ID: 1812756
    [No Abstract]   [Full Text] [Related]  

  • 5. Cloning, expression, and mutagenesis of SIVmac proteinase in E. coli.
    Corr BR; Richardson M; Wilderspin AF
    Biochem Soc Trans; 1992 May; 20(2):160S. PubMed ID: 1397549
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular modeling of the HIV-2 protease.
    Gustchina A; Weber IT; Wlodawer A
    Adv Exp Med Biol; 1991; 306():549-53. PubMed ID: 1812757
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.
    Powell DJ; Bur D; Wlodawer A; Gustchina A; Payne SL; Dunn BM; Kay J
    Eur J Biochem; 1996 Oct; 241(2):664-74. PubMed ID: 8917470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of precursor and tethered dimer forms of HIV proteinase.
    Phylip LH; Griffiths JT; Mills JS; Graves MC; Dunn BM; Kay J
    Adv Exp Med Biol; 1995; 362():467-72. PubMed ID: 8540359
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
    Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diastereoselective reduction of protein-bound methionine sulfoxide by methionine sulfoxide reductase.
    Sharov VS; Ferrington DA; Squier TC; Schöneich C
    FEBS Lett; 1999 Jul; 455(3):247-50. PubMed ID: 10437782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis.
    Culberson JC; Bush BL; Sardana VV
    Methods Enzymol; 1994; 241():385-94. PubMed ID: 7854190
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
    Tomasselli AG; Heinrikson RL
    Methods Enzymol; 1994; 241():279-301. PubMed ID: 7854182
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions.
    Rosé JR; Salto R; Craik CS
    J Biol Chem; 1993 Jun; 268(16):11939-45. PubMed ID: 8505318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for specificity of retroviral proteases.
    Wu J; Adomat JM; Ridky TW; Louis JM; Leis J; Harrison RW; Weber IT
    Biochemistry; 1998 Mar; 37(13):4518-26. PubMed ID: 9521772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diastereoselective protein methionine oxidation by reactive oxygen species and diastereoselective repair by methionine sulfoxide reductase.
    Sharov VS; Schöneich C
    Free Radic Biol Med; 2000 Nov; 29(10):986-94. PubMed ID: 11084287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of human immunodeficiency virus protease cleavage sites in proteins.
    Chou KC
    Anal Biochem; 1996 Jan; 233(1):1-14. PubMed ID: 8789141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant immobilized rhizopuspepsin as a new tool for protein digestion in hydrogen/deuterium exchange mass spectrometry.
    Rey M; Man P; Brandolin G; Forest E; Pelosi L
    Rapid Commun Mass Spectrom; 2009 Nov; 23(21):3431-8. PubMed ID: 19827048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal and polyclonal antibodies: reagents for studying HIV-1 proteinase variants.
    Stoller TJ; Lim JJ; Woltizky BA; Graves MC
    Adv Exp Med Biol; 1991; 306():507-10. PubMed ID: 1812750
    [No Abstract]   [Full Text] [Related]  

  • 19. BYC, an atypical aspartic endopeptidase from Rhipicephalus (Boophilus) microplus eggs.
    Nascimento-Silva MC; Leal AT; Daffre S; Juliano L; da Silva Vaz I; Paiva-Silva Gde O; Oliveira PL; Sorgine MH
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Apr; 149(4):599-607. PubMed ID: 18242110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling of the structure of FIV protease.
    Gustchina A
    Adv Exp Med Biol; 1995; 362():479-84. PubMed ID: 8540361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.